About UsContact UsMy AccountView Cart
Home » BusIntell Reports » Health Care Information Technology / Drug Distributors / Medical Equipment / Patient Safety » McKesson Corporation BusIntell Report

Publication Details

McKesson Corporation BusIntell Report

Generic Keywords: (What are these?)
Knowledge Source, Healthcare Market, BusIntell, Reports, Medical, Information, HMO, Pharmacare, Diagnostic


Publication Date: 16-JUN-08
Pages: 145
Format: PDF
Price: $295.00
Delivery: Immediate Online Access
   

Description

McKesson Corporation (McKesson), founded in 1833, conducts its business through two segments. McKesson's strategy is to create strong, value-based relationships with customers, enabling it to sell additional products and services to these customers over time. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs, medical-surgical supplies and equipment, and health and beauty care products throughout North America. This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, sells pharmacy software and provides consulting, outsourcing and other services. This segment includes a 49% interest in Nadro, S.A. de C.V., the leading pharmaceutical distributor in Mexico and a 39% interest in Parata Systems, LLC, which sells automated pharmacy and supply management systems and services to retail and institutional outpatient pharmacies. The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions, pharmacy automation for hospitals, as well as connectivity, outsourcing and other services. McKesson's Payor group of businesses, which includes its InterQual®, clinical auditing and compliance and medical management software businesses and our care management programs, are also included in this segment. The segment's customers include hospitals, physicians, homecare providers, retail pharmacies and payors from North America, the United Kingdom, other European countries and Asia Pacific.

Table of Contents


  1. 1.0 Industry Overview/Trends - pgs. 4-15
    2.0 Company Overview - pgs. 17-23
    3.0 Corporate Strategy - pgs. 25-29
    3.1 Strengths/Weaknesses - pg. 30
    4.0 Company Executives - pgs. 32-33
    5.0 Financial Information - pgs. 35-41
    6.0 Lines of Business - pgs. 43-143
    6.1 Technology Solutions - pgs. 43-108
    6.2 Distribution Solutions - pgs. 109-143
    7.0 Sources - pg. 145

Home
BusIntell Reports
Pharmaceutical Brand Briefings
Conference Interviews
HealthDot Pharma Report
Spotlight
Custom Research
Content Map

Advanced Search



HomeHealthcare Market OverviewsBusIntell ReportsEvents on DemandSpotlightCustom ResearchContent Map